Freedom from Price Gouging Act
This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under Medicare that cost $100 or more and for which the average manufacturer price increases faster than inflation.
Action Date | Type | Text | Source |
---|---|---|---|
2021-04-21 | Committee | Referred to the Subcommittee on Health. | House committee actions |
2021-04-20 | Committee | Referred to the Subcommittee on Social Security. | House committee actions |
2021-04-20 | Committee | Referred to the Subcommittee on Health. | House committee actions |
2021-04-20 | IntroReferral | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
2021-04-20 | IntroReferral | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
2021-04-20 | IntroReferral | Introduced in House | Library of Congress |